The Cancering Show
In this episode, Dr. JYP welcomes back , a seasoned oncologist who specializes in supportive oncology. Dr. Butler shares his journey from humble beginnings and a fascination with science to a career in cancer care, emphasizing the importance of addressing both the physical and emotional needs of patients. He discusses the distinction between palliative and supportive care, advocating for an approach that supports patients throughout their cancer journey — not just at the end of life. Dr. Butler also offers personal insights from his own cancer diagnosis, reflecting on what he has learned...
info_outlineThe Cancering Show
In this episode, Dr. JYP talks with , a surgical oncologist who specializes in melanoma. Dr. Howard explains that not all skin cancers are the same, emphasizing that melanoma is more dangerous compared with basal cell and squamous cell carcinomas. He highlights the importance of detecting melanoma early, as it is the most dangerous form of skin cancer. They discuss surgical and systemic treatment advancements, including the practice of sentinel lymph node biopsy and the game-changing benefits of immunotherapy. Dr. Howard says clinical trials are essential in improving treatment methods and...
info_outlineThe Cancering Show
In this episode, Dr. JYP welcomes , a trained art therapist who works with patients at the USA Health Mitchell Cancer Institute. Margaret delves into her personal journey, from discovering art therapy to implementing it in cancer care in Mobile, Alabama. She describes art therapy as a marriage between art and psychology, emphasizing its benefits for cancer patients in creating hope, reducing anxiety, and bringing purpose to the cancer journey. She shares stories about how art can turn clinical spaces into environments of light and creativity. Sponsored by the , the MCI’s art therapy...
info_outlineThe Cancering Show
In this episode, Dr. JYP welcomes medical oncologist and hematologist Dr. Daisy Escobar to discuss her background and her expertise in cancer diagnosis and treatment. Dr. Escobar shares her journey to the Mitchell Cancer Institute and talks about her family. The conversation focuses on cell-free DNA technology, also known as liquid biopsy, which is used primarily for cancer surveillance and monitoring. Dr. Escobar explains the benefits and limitations of this technology, including how it compares with traditional biopsies and its potential in early cancer detection. The conversation also...
info_outlineThe Cancering Show
In this episode, Dr. JYP and State Health Officer Dr. Scott Harris discuss the intersection of infectious disease and cancer in Alabama. Dr. Harris shares insights into the state's cancer trends, including the impact of delayed screenings during the pandemic, and disparities in cancer outcomes based on geography and race. They discuss the collaborative efforts among state agencies, nonprofits, and medical communities to combat cancer. They also delve into Alabama's strategic initiative, Operation Wipe Out, aimed at eliminating cervical cancer through vaccination, screening, and treatment....
info_outlineThe Cancering Show
In this heartfelt episode of The Cancering Show, Dr. JYP welcomes back Chaplain Kim Crawford Meeks to discuss the complexities of celebrating the holidays while dealing with cancer. They explore the bittersweet nature of the season, emphasizing the importance of modifying expectations, planning ahead, and cherishing moments with loved ones. Chaplain Kim shares practical advice on managing emotions, supporting family members, and including children in celebrations. They also discuss commemorating a loved one who is no longer present, and ensuring everyone feels valued and included. Whether...
info_outlineThe Cancering Show
In this episode, Dr. JYP speaks with Leah Phillips, a nonsmoker diagnosed with stage 4 non-small cell lung cancer in 2019. Leah emphasizes the importance of self-awareness and self-advocacy in health, sharing her journey from initial misdiagnosis to targeted therapy success. Despite an initial prognosis of six to 12 months to live, Leah has surpassed expectations with a targeted drug that led to significant tumor reduction and stability for over four years. Leah discusses her participation in clinical trials, the benefits of multimodal therapy, and her role in the . For more about Leah, see...
info_outlineThe Cancering Show
In this episode, Dr. JYP and guest Susan Crutchfield discuss the complexities of tobacco addiction and strategies for quitting smoking. They highlight the importance of nonjudgmental support, individual motivations ("your why"), and the availability of various medications and therapies. The dangers of vaping, especially among youth, are also covered, emphasizing nicotine's addictive nature and health risks. The Great American Smokeout is promoted as an event that encourages smoking cessation through peer-to-peer engagement. The significance of early lung cancer detection, particularly through...
info_outlineThe Cancering Show
Dr. JYP concludes a three-part series focused on understanding the most common medical reports received by Cancering patients. This episode delves into pathology reports and how patients can use them to better understand their condition. Dr. JYP describes the key elements of pathology reports and defines terms such as "benign," "malignant," “carcinoma,” and “sarcoma.” She discusses how detailed reports from biopsies aid in staging cancer and the implications for treatment options. She reminds listeners that pathology reports should always be discussed with a doctor, and that reviewing...
info_outlineThe Cancering Show
Dr. JYP continues a three-part series focused on understanding the most common medical reports received by Cancering patients. In this second episode, she discusses blood chemistry panels. She explains common abbreviations suck as BNP (basic metabolic panel) and CNP (comprehensive metabolic panel), guiding listeners through key components including sodium (NA), potassium (K), magnesium (MAG), kidney function tests (BUN and creatinine), and glucose levels. She discusses the importance of understanding normal ranges, the potential causes for abnormalities and the most common questions patients...
info_outlineOn this episode, Dr. Jennifer Young Pierce talks with Dr. Martin Heslin, a surgical oncologist and the director of the USA Health Mitchell Cancer Institute, about the future of cancer treatment, what it means to cure cancer, the advancements in genetics and the importance of building personal relationships throughout the cancer journey.
Key Takeaways
- Your physician needs to be more than biology, science and facts; physicians need to build a relationship with their patients and support team.
- One of the hardest conversations for a physician is to explain to a patient and the family that surgery is not the best option.
- For every different type of cell in your body, there is a different type of cancer.
- People fail to recognize that cancer is a part of yourself. Your body takes care of cancer cells every single day of your life.
- The future of cancer treatment may be understanding all the details of the mechanism of cancer and how we can alter those mechanisms in real time.
- To say to cure cancer as a single swipe of the sword won't happen because different cells have different reasons (for why) they go haywire.
- A cancer cure means you die of something else.
- Cancer for every patient means 100 percent coming back, or it's a zero percent chance of coming back.
Dr. Martin Heslin Said:
I want to be the patient and family's greatest advocate to put your cape on, go in and save the day, do the big operation, and cure some people from a challenging disease, but it's also about the relationship.
Patients should ask three questions: Are you going to cure me? Are you going to make me live longer? Are you going to make me live better?
As we understand "the biology," I think our ability to define and personalize cancer therapy will be much greater.
A cancer cure means you die of something else. Some cancers you die with, and some cancers you die from. It's our job as cancer physicians and cancer coaches, if you will, to guide patients and their families through that process.
Dr. JYP Said:
When I describe a cancer cure to patients, I usually say that your labs are normal, your CT scans are normal, you have no evidence of cancer in your body, and that is over some time frame. If the cancer hasn't come back after that specified period of time, you are most likely cured.
There's so much that we don't know now that we're operating blind to say we think you have a certain percentage risk that this will come back. But as one of my professors said to me, that's all 1's and 0's. It's either 100 percent coming back, or it's a zero percent chance of coming back. It's just that we can't tell with our current and limited knowledge.
//////
Never Miss an Episode
Please subscribe to The Cancering Show
Want us to deliver The Cancering Show to your email inbox?
Let us know by contacting Dr. JYP at cancering.com.
Thanks for listening to The Cancering Show, brought to you by USA Health Mitchell Cancer Institute.
Please subscribe, rate and review The Cancering Show wherever you listen to your favorite podcasts.
Until next time, be healthy, happy and always thriving.
USA Health Mitchell Cancer Institute
The Cancering Show is brought to you by USA Health Mitchell Cancer Institute. MCI is a cutting-edge cancer research and treatment center built to fight cancer smarter in Mobile and Baldwin counties in Alabama. Our researchers and clinicians focus daily on the struggle against cancer, serving a potential catchment population of more than 4.1 million people, with a singular focus of advancing cancer diagnosis, treatment, and prevention throughout the Gulf Coast and beyond with science, technology and hope.
Want to know more about the Mitchell Cancer Institute?
Visit us at usamci.com or search for us on Facebook, Twitter and Instagram.
Mitchell Cancer Institute is a member of USA Health.
To learn more about all of USA Health hospitals, clinics and services, visit usahealthsystem.com.